Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Louis

Showing results (521-530 of 576) with videos related to

Pageof 58
Sort By:
Clinical Cardiology|April 12, 2008
Enhanced external counterpulsation in the treatment of chronic refractory angina: a long-term follow-up outcome from the International Enhanced External Counterpulsation Patient RegistryPoay Huan Loh, John G F Cleland, Amal A Louis, et al.
Journal of Clinical Microbiology|March 23, 2010
Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and MexicoHoonmo L Koo, Nadim J Ajami, Zhi-Dong Jiang, et al.
NPJ Vaccines|February 1, 2025
Safety and immunogenicity in humans of enterotoxigenic Escherichia coli double mutant heat-labile toxin administered intradermallyMarcela F Pasetti, Patricia L Milletich, Jessica A White, et al.
Obesity Science & Practice|September 27, 2016
Perceived helpfulness of the individual components of a behavioural weight loss program: results from the Hopkins POWER TrialA T Dalcin, G J Jerome, S L Fitzpatrick, et al.
Obesity (Silver Spring, Md.)|January 6, 2015
Willingness to pay for continued delivery of a lifestyle-based weight loss program: The Hopkins POWER trialGerald J Jerome, Reza Alavi, Gail L Daumit, et al.
Vaccine|December 20, 2018
A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunizationDavid I Bernstein, Marcela F Pasetti, Rebecca Brady, et al.
Physical Chemistry Chemical Physics : PCCP|October 15, 2013
Coarse-graining DNA for simulations of DNA nanotechnologyJonathan P K Doye, Thomas E Ouldridge, Ard A Louis, et al.
Vaccine|July 9, 2005
Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potencyFubao Wang, Alan C Puddy, Bill C Mathis, et al.
Journal of the National Cancer Institute|July 5, 2001
National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000P Eifel, J A Axelson, J Costa, et al.
Plos One|March 29, 2018
Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity scoreChad K Porter, Amanda Lynen, Mark S Riddle, et al.
Pageof 58

Showing results (521-530 of 576) with videos related to

Sort By:
Pageof 58
Clinical Cardiology|April 12, 2008
Enhanced external counterpulsation in the treatment of chronic refractory angina: a long-term follow-up outcome from the International Enhanced External Counterpulsation Patient RegistryPoay Huan Loh, John G F Cleland, Amal A Louis, et al.
Journal of Clinical Microbiology|March 23, 2010
Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and MexicoHoonmo L Koo, Nadim J Ajami, Zhi-Dong Jiang, et al.
NPJ Vaccines|February 1, 2025
Safety and immunogenicity in humans of enterotoxigenic Escherichia coli double mutant heat-labile toxin administered intradermallyMarcela F Pasetti, Patricia L Milletich, Jessica A White, et al.
Obesity Science & Practice|September 27, 2016
Perceived helpfulness of the individual components of a behavioural weight loss program: results from the Hopkins POWER TrialA T Dalcin, G J Jerome, S L Fitzpatrick, et al.
Obesity (Silver Spring, Md.)|January 6, 2015
Willingness to pay for continued delivery of a lifestyle-based weight loss program: The Hopkins POWER trialGerald J Jerome, Reza Alavi, Gail L Daumit, et al.
Vaccine|December 20, 2018
A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunizationDavid I Bernstein, Marcela F Pasetti, Rebecca Brady, et al.
Physical Chemistry Chemical Physics : PCCP|October 15, 2013
Coarse-graining DNA for simulations of DNA nanotechnologyJonathan P K Doye, Thomas E Ouldridge, Ard A Louis, et al.
Vaccine|July 9, 2005
Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potencyFubao Wang, Alan C Puddy, Bill C Mathis, et al.
Journal of the National Cancer Institute|July 5, 2001
National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000P Eifel, J A Axelson, J Costa, et al.
Plos One|March 29, 2018
Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity scoreChad K Porter, Amanda Lynen, Mark S Riddle, et al.
Pageof 58